Contact
Please use this form to send email to PR contact of this press release:
MacroGenics Announces Termination of Duvortuxizumab Collaboration and License Agreement with Janssen
TO:
Please use this form to send email to PR contact of this press release:
MacroGenics Announces Termination of Duvortuxizumab Collaboration and License Agreement with Janssen
TO: